Six things to know:
1. Net sales were $5.4 billion. The company’s medsurg and neurotechnology segment saw $3.1 billion in sales, an 9% increase year-over-year.
2. Orthopedic and spine sales grew 7.9% year-over-year with $2.3 billion in sales.
3. Hip sales were $428 million, a 8.9% increase year-over-year. Knee sales were $602 million, a 7.1% increase year-over-year.
4. Trauma and extremity sales were $832 million, a 8.6% increase year-over-year.
5. Spine sales were $307 million, a 3.8% increase year-over-year.
6. Stryker’s net earnings of $825 million represent an 11.8% increase from the same time in 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
